Send me real-time posts from this site at my email
Voting is over

Acadia Pharmaceuticals Will Climb $35+ After Earnings

Acadia Pharmaceuticals is reporting tomorrow after the market close. Most of the analysts issued either 'Outperform' (8) or 'Buy' (2) recommendation and just 3 analysts said 'Hold'.

Acadia's revenue is growing significantly and I think it will keep growing this quart a well, moreover, it might double compared to Q4'2016. According to Financial Times, revenue consensus is about $15.9M:

If Acadia beats revenue, then it goes higher. EPS doesn't matter at the moment for them. Acadia will most likely go higher than $35 right after the earnings call.

Agree or Disagree? 

1 person

Acadia Pharmaceuticals Will Climb $35+ After Earnings

Voting is over
Waiting for
the right answer
1 person
0 people

Welcome!!! Is it your First time here?

What are you looking for? Select your points of interest to improve your first-time experience:

Apply & Continue